Inherent Biosciences

Salt Lake City, UT · Founded 2019 · Privately Held (backing)

Developer of an epigenetic medicine platform designed to tackle health issues by overhauling the trial-and-error methodology. Inherent Biosciences is based in Salt Lake City, UT and was founded in 2019. It was valued at $18.1 million at its early-stage round in Sep 2022, the last priced event on record. It has raised $9.8 million across 1 recorded round; the latest was a $1.5 million seed round in Aug 2022.

PMV mark · valuation
$18.1M
Oct 2026
Priced at
its early-stage round
Sep 2022
Total raised
$9.8M
Last round
Seed Round
Aug 2022
What is Inherent Biosciences worth?
$18.1MPrivateMarketView mark · Oct 2026

Valued at $18.1M at its early-stage round, Sep 2022. Nothing has traded since.

Free account
More of Inherent Biosciences with a free account
  • ·The complete investor list: 18 names
  • ·Watch Inherent Biosciences: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Valuation timeline

0 priced rounds · 32 daily marks since · Sep 2026 – Oct 2026
▮▮
Markrounds hold their value until the next priced eventMark, today
log scale
Post-money values unlock with a free account.Unlock the axis

Membership and data by Private Market View

Inherent Biosciences funding history

1 rounds
DateRoundRaisedPost-money
Aug 2022Seed Round$1.5M▮
Unlock post-money valuations

Membership and data by Private Market View

Inherent Biosciences valuation

Inherent Biosciences was valued at $18.1 million at its early-stage round in Sep 2022. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.

How much has Inherent Biosciences raised?

Inherent Biosciences has raised $9.8 million in total; 1 of its rounds is on record. The largest on record was a $1.5 million seed round in Aug 2022.

Inherent Biosciences has filed 1 Form D with the SEC, most recently in May 2023 ($1.5 million sold to 12 investors).

How Inherent Biosciences's valuation is determined

Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.

For Inherent Biosciences, the most current credible signal sets the number and the older ones confirm it: a live secondary-market price first, then three or more recent prints, then institutional fund marks, and otherwise the last priced round, which never decays. The valuation is the last round’s post-money moved by the price change since that round, so no share count is assumed. Today it is set by its last priced round. Question about this number? Full methodology →

Frequently asked about Inherent Biosciences

What is Inherent Biosciences worth?
Inherent Biosciences is valued at $18.1M as of Oct 2026. Valued at $18.1M at its early-stage round, Sep 2022. Nothing has traded since.
How much has Inherent Biosciences raised?
Inherent Biosciences has raised $9.8M in total funding across 1 recorded rounds.
When did Inherent Biosciences last raise?
Inherent Biosciences last raised in Aug 2022 (Seed Round), raising $1.5M.